Isolated patellofemoral arthritis occurs in up to 10% of patients suffering osteoarthritis of the knee. Previous reports of several different patellofemoral designs have given indifferent results. The Lubinus prosthesis has been shown to have a 50% failure rate at eight years in a study of 76 cases. The main reasons for failure were mal-alignment, wear, impingement and disease progression. As a result of these studies, a new prosthesis was designed to solve some of these problems.

The Avon patellofemoral arthroplasty was first implanted in September 1996. The cases have been entered into a prospective review with evaluations at eight months, two years and five years. The outcome was assessed using pain scores, Bartlett’s patella score and the Oxford knee score. To date, 186 knees have been treated; over 100 knees have been reviewed at two years and 20 knees at five years. The main pain score improved from a pre-operative level of 13.5 points out of 40 to 33.5 points at two years and 36 at five years. The mean pre-operative movement was 109° and this increased to 120° at five years. The Bartlett patella score improved from a pre-operative level of 10.5 points out of 30 pre-operatively to 23 points at two years and 25 at five years. The Oxford knee score was 20 points out of 48 pre-operatively and this improved to 35 points at two years and 40 points at five years. One patient developed subluxation, which required distal soft tissue realignment. No other patient has developed problems with alignment or wear. Ten knees have developed evidence of disease progression usually in the medial compartment of which six have required revision to a total knee replacement.

The results to date suggest that this improved design has all but eliminated the previous problems of malalignment and early wear. The functional results are as good or better than those of a total knee replacement. There is a low complication rate and an excellent range of movement. Disease progression remains a potential problem. This type of prosthesis offers a reasonable alternative to total knee replacement in this small group of patients with isolated, early patellofemoral disease.